9 3 7206
Pill imprint 9 3 7206 has been identified as Mirtazapine 15 mg.
Mirtazapine is used in the treatment of depression; anxiety; insomnia; hot flashes; post traumatic stress disorder and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy.
Mirtazapine 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Mirtazapine Images
- Imprint:
-
9 3
7206 - Strength:
- 15 mg
- Color:
- Yellow
- Size:
- 7.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
corn starch
hypromelloses
lactose monohydrate
magnesium stearate
polyethylene glycol 400
povidone
titanium dioxide
ferric oxide yellow
polyethylene glycol 6000
- Drug Class:
- Tetracyclic antidepressants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7206
| NDC Code | Manufacturer / Repackager |
|---|---|
| 63739-0355 | McKesson Packaging Services |
| 68115-0293 | Dispensexpress Inc (repackager) |
| 68071-0486 | Nucare Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
More Mirtazapine resources
- Mirtazapine (Wolters Kluwer)
- Mirtazapine Orally Disintegrating Tablets (Wolters Kluwer)
- mirtazapine (Cerner Multum)
- Remeron RD (Micromedex) - Includes Dosage Information
- mirtazapine (Micromedex) - Includes Dosage Information
- Mirtazapine (AHFS DI)
- Mirtazapine Orally Disintegrating Tablets (FDA)
- Mirtazapine Tablets (FDA)
- Remeron Tablets (FDA)
- Mirtazapine (Wolters Kluwer)


